October 2017

CareDx Completes $20 Million Public Offering

United States - Minnesota

Craig-Hallum Capital Group, acting as the sole book-running manager, and H.C. Wainwright & Co., acting as co-manager, completed an upsized $20.0 million public offering of common stock for CareDx, Inc., a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients. The offering closed on October 10, 2017. Our firm represented the underwriters in the transaction.

Related Legal Services

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.